Peachtree Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,930
Closed -$207K 79
2018
Q3
$207K Buy
+1,930
New +$193K 0.14% 75
2018
Q1
Sell
-4,360
Closed -$368K 78
2017
Q4
$368K Hold
4,360
0.28% 66
2017
Q3
$373K Hold
4,360
0.32% 62
2017
Q2
$359K Hold
4,360
0.31% 65
2017
Q1
$367K Hold
4,360
0.34% 62
2016
Q4
$321K Hold
4,360
0.32% 74
2016
Q3
$350K Hold
4,360
0.34% 65
2016
Q2
$343K Sell
4,360
-6,000
-58% -$452K 0.35% 72
2016
Q1
$746K Hold
10,360
0.75% 43
2015
Q4
$873K Hold
10,360
0.91% 39
2015
Q3
$867K Hold
10,360
0.9% 37
2015
Q2
$865K Hold
10,360
0.65% 48
2015
Q1
$753K Hold
10,360
0.54% 55
2014
Q4
$715K Sell
10,360
-955
-8% -$64.5K 0.48% 61
2014
Q3
$734K Hold
11,315
0.49% 58
2014
Q2
$703K Sell
11,315
-120
-1% -$7.16K 0.47% 61
2014
Q1
$673K Hold
11,435
0.46% 63
2013
Q4
$583K Buy
+11,435
New +$573K 0.4% 73

Other funds holding LLY

Peachtree Investment Advisors's LLY Position: Q4 2018 in Review

Peachtree Investment Advisors sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 1,930 shares — an estimated $207K sold.

Peachtree Investment Advisors first reported a position in LLY in Q4 2013 and held it in 18 quarters. The position peaked at $873K in Q4 2015. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

  • Peachtree Investment Advisors reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
  • Peachtree Investment Advisors sold 1,930 Eli Lilly shares in Q4 2018, an estimated $207K.
  • Peachtree Investment Advisors first reported a position in Eli Lilly in Q4 2013 and held it in 18 quarters.
  • Peachtree Investment Advisors's Eli Lilly position peaked at $873K in Q4 2015.
  • 1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Peachtree Investment Advisors's 13F filing for Q4 2018, filed 14 Jan 2019.